Healthcare ETF Looking Robust

Healthcare ETF Looking Robust
By Mike Paulenoff,

Many of the major components of the SPDR Select Healthcare ETF (AMEX: XLV) have been acting well technically and exhibiting patterns that argue for more upside directly. These include Johnson & Johnson (JNJ), Merck (MKR), Pfizer (PFE) and Eli Lilly (LLY). Let's expect continued strength in the ETF that next confronts a key 8-week resistance line, now at 25.35/40. If hurdled that will trigger upside follow-through towards my optimal target zone of 27.20/60.

  • Action-Oriented Trade Set-Ups in Stocks & ETFs
  • Macro Analysis of the Broader Markets
  • Detailed Technical Guidance for each Trading Idea
  • Live Interaction w/ Mike & Our Member Community
  • And Much, Much More!
Join Now! - Special Offer!
Veteran Wall Street analyst and financial author, Mike provides detailed and timely analysis and trade set-ups on a range of markets. Read more...

Have Mike's “Out Front” morning analysis delivered FREE to your email inbox twice weekly!